Kisspeptin Administration in the Adult
Administration of Kisspeptin to Subjects With Reproductive Disorders
Sponsor: Massachusetts General Hospital
This PHASE1 trial investigates GnRH Deficiency and Hyperprolactinemia and is currently completed. Massachusetts General Hospital leads this study, which shows 18 recorded versions since 2009 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
18 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1
-
Aug 2023 — Jul 2024 [monthly]
Recruiting PHASE1
-
Sep 2022 — Aug 2023 [monthly]
Recruiting PHASE1
▶ Show 13 earlier versions
-
Jan 2022 — Sep 2022 [monthly]
Recruiting PHASE1
-
Sep 2021 — Jan 2022 [monthly]
Recruiting PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Jan 2020 — Jul 2020 [monthly]
Recruiting PHASE1
-
Jul 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Jan 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
Jul 2018 — Jan 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Apr 2017 — Aug 2017 [monthly]
Recruiting PHASE1
Phase: PHASE2 → PHASE1
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Boston, United States